Regulators of gene expression in Enteric Neural Crest Cells are putative Hirschsprung disease genes by Schriemer, Duco et al.
 
 
 University of Groningen
Regulators of gene expression in Enteric Neural Crest Cells are putative Hirschsprung
disease genes
Schriemer, Duco; Sribudiani, Yunia; IJpma, Arne; Natarajan, Dipa; MacKenzie, Katherine C.;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Schriemer, D., Sribudiani, Y., IJpma, A., Natarajan, D., MacKenzie, K. C., Metzger, M., Binder, E., Burns,
A. J., Thapar, N., Hofstra, R. M. W., & Eggen, B. J. L. (2016). Regulators of gene expression in Enteric
Neural Crest Cells are putative Hirschsprung disease genes. Developmental Biology, 416(1), 255-265.
https://doi.org/10.1016/j.ydbio.2016.06.004
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Developmental Biology 416 (2016) 255–265Contents lists available at ScienceDirectDevelopmental Biologyhttp://d
0012-16
n Corr
E-mjournal homepage: www.elsevier.com/locate/developmentalbiologyGenomes and Developmental ControlRegulators of gene expression in Enteric Neural Crest Cells are putative
Hirschsprung disease genes
Duco Schriemer a, Yunia Sribudiani b,c, Arne IJpma d, Dipa Natarajan e,
Katherine C. MacKenzie b, Marco Metzger e,f, Ellen Binder e, Alan J. Burns b,e,
Nikhil Thapar e,g, Robert M.W. Hofstra b,e, Bart J.L. Eggen a,n
a Department of Neuroscience, section Medical Physiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
b Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
c Department Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
d Department of Bioinformatics, Erasmus University Medical Center, Rotterdam, The Netherlands
e Stem Cells and Regenerative Medicine, Birth Defects Research Centre, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
f Fraunhofer IGB, Wuerzburg branch and Chair Tissue Engineering and Regenerative Medicine, University Hospital Wuerzburg, Wuerzburg, Germany
g Division of Neurogastroenterology and Motility, Department of Gastroenterology, Great Ormond Street Hospital for Children NHS Foundation Trust, London,
United Kingdoma r t i c l e i n f o
Article history:
Received 30 September 2015
Received in revised form
17 May 2016
Accepted 2 June 2016






06/& 2016 Elsevier Inc. All rights reserved.
esponding author.
ail address: b.j.l.eggen@umcg.nl (B.J.L. Eggen).a b s t r a c t
The enteric nervous system (ENS) is required for peristalsis of the gut and is derived from Enteric Neural
Crest Cells (ENCCs). During ENS development, the RET receptor tyrosine kinase plays a critical role in the
proliferation and survival of ENCCs, their migration along the developing gut, and differentiation into
enteric neurons. Mutations in RET and its ligand GDNF cause Hirschsprung disease (HSCR), a complex
genetic disorder in which ENCCs fail to colonize variable lengths of the distal bowel. To identify key
regulators of ENCCs and the pathways underlying RET signaling, gene expression profiles of untreated
and GDNF-treated ENCCs from E14.5 mouse embryos were generated. ENCCs express genes that are
involved in both early and late neuronal development, whereas GDNF treatment induced neuronal
maturation. Predicted regulators of gene expression in ENCCs include the known HSCR genes Ret and
Sox10, as well as Bdnf, App and Mapk10. The regulatory overlap and functional interactions between these
genes were used to construct a regulatory network that is underlying ENS development and connects to
known HSCR genes. In addition, the adenosine receptor A2a (Adora2a) and neuropeptide Y receptor Y2
(Npy2r) were identified as possible regulators of terminal neuronal differentiation in GDNF-treated
ENCCs. The human orthologue of Npy2r maps to the HSCR susceptibility locus 4q31.3-q32.3, suggesting a
role for NPY2R both in ENS development and in HSCR.
& 2016 Elsevier Inc. All rights reserved.1. Introduction
The enteric nervous system (ENS) of the gastrointestinal tract is
composed of neurons and glial cells that are organized in inter-
connected ganglia in the myenteric and submucosal plexuses. The
ENS controls the peristaltic movements of the bowel, fluid ex-
change between the gut and its lumen, and local blood flow
(Furness, 2006; Gershon, 2005). In vertebrates, the ENS is entirely
derived from neural crest cells (Le Douarin and Kalcheim, 1999).
Vagal (hindbrain) neural crest cells invade the foregut at around
E9 in mice (Durbec et al., 1996b), at which point they are referred
to as Enteric Neural Crest Cells (ENCCs). The intestinal wall iscolonized by ENCCs in a rostral to caudal direction between E9 and
E15 in mice and sacral neural crest cells contribute to colonization
of the hindgut late during ENS development (Burns and Douarin,
1998; Druckenbrod and Epstein, 2005). A subset of Schwann cell
precursors invades the gut postnatally and contributes up to 20%
of the neurons in the colon (Uesaka et al., 2015).
Glial cell line Derived Neurotrophic Factor (GDNF) acts as a
chemoattractant to migrating vagal ENCCs and directs the migra-
tion of ENCCs along the gut (Young et al., 2001). ENCCs express the
REarranged during Transfection (RET) receptor tyrosine kinase,
and RET with its co-receptor GFRα1 is the receptor for GDNF
(Durbec et al., 1996a). Mice lacking Ret, Gfrα1 or Gdnf fail to co-
lonize the bowel beyond the stomach, leading to intestinal agan-
glionosis (Enomoto et al., 1998; Moore et al., 1996; Pichel et al.,
1996; Sánchez et al., 1996; Schuchardt et al., 1994). Besides its role
in migration, RET signaling is important for proliferation of ENCCs
D. Schriemer et al. / Developmental Biology 416 (2016) 255–265256at E12 and for their survival at E14-E16 in mice (Chalazonitis et al.,
1998; Gianino et al., 2003; Taraviras et al., 1999; Uesaka et al.,
2008). In order to develop into a mature ENS, post-migratory
ENCCs differentiate into various neuronal subtypes and glial cells.
GDNF promotes neuronal, but not glial differentiation of ENCCs in
vitro, and acts as a chemoattractant to outgrowing neurites (Hearn
et al., 1998; Natarajan et al., 2002; Taraviras et al., 1999; Young
et al., 2001). The mature ENS contains sensory neurons, inter-
neurons and excitatory and inhibitory motor neurons that use a
wide range of neurotransmitters, similar to those found in the CNS
(Hao and Young, 2009).
Mutations in RET and GDNF in humans contribute to Hirsch-
sprung disease (HSCR), a congenital disorder that is characterized
by intestinal aganglionosis in a variable segment of the distal gut.
HSCR patients present with tonic contraction of the muscle layers
in the affected segment, which consequently leads to dilatation of
the proximal bowel. The prevalence of HSCR is 1:5000 live births
and it is considered an inherited disease. Based on the families
reported, the mode of inheritance can differ. Most non-syndromic
familial HSCR cases show a dominant pattern of inheritance,
mostly with reduced penetrance, whereas many syndromic HSCR
families show a recessive pattern of inheritance. The sporadic
cases are considered polygenic or oligogenic. Of the approximately
15 HSCR genes identified so far, the RET gene is by far the most
important gene. Coding mutations in RET are found in 50% of
familial and 15–35% of sporadic HSCR patients and represent the
great majority of genetic mutations found in HSCR patients (Attié
et al., 1995; Hofstra et al., 2000). Mutations in all other HSCR-as-
sociated genes, including GDNF, are rare (Alves et al., 2013; Amiel
et al., 2008; Brooks et al., 2005a).
The colonization of the intestine by ENCCs, followed by their
neuronal and glial differentiation, is a complex process controlled
by various signaling pathways. These include Hedgehog, NOTCH,
WNT, Retinoic acid and TGF-β/BMP signaling (Goldstein et al.,
2005; Ikeya et al., 1997; Okamura and Saga, 2008; Ramalho-Santos
et al., 2000; Sato and Heuckeroth, 2008). Several other pathways
that are important for ENS development have been identified in
gene expression profiling studies. Iwashita et al. (2003) reported
that the HSCR genes Ret, Gfrα1, Ednrb and Sox10 are highly ex-
pressed by ENCCs in mice, thereby explaining how mutations in
these genes contribute to aganglionosis. A subsequent expression
study by Heanue and Pachnis (2006) showed that at E15.5 in mice,
ENCCs express markers of early and late neuronal development
and glial differentiation, representing different stages of ENS de-
velopment. These authors identified Sox2, Cart, Sema, Fgf and Jnk
as novel signaling pathways in ENCCs (Heanue and Pachnis, 2006).
In addition, Vohra et al. (2006) found that E14 mouse ENCCs highly
express genes with synaptic functions and showed that these
genes are important for ENCC migration and neurite outgrowth.
Some insight in the pathways downstream of RET signaling has
come from expression profiling of GDNF-treated ENCCs by Ngan
et al. (2008), who analyzed the changes in gene expression in
ENCCs after 8 and 16 h of GDNF treatment. These authors showed
that the Prokineticin pathway is activated by RET signaling, but
found that few other genes were differentially expressed by the
short-term GDNF treatment of ENCCs (Ngan et al., 2008).
These gene expression studies have focused on individual
genes that are highly expressed by ENCCs and showed that some
of these genes are critical for the development of the ENS. How-
ever, for many highly expressed genes it is still unknown if and
how they contribute to ENS development. In this study, we used
an unbiased, systematic pathway analysis to identify the biological
processes that are important for ENS development. Moreover, we
treated ENCC cultures with GDNF for 14 days to identify the stable,
long-term gene expression changes induced by RET signaling. We
show that the expression of differentially expressed genes isregulated by known ENS-related genes, and by several genes not
previously implicated in ENS development. These regulatory genes
present novel candidates genes for HSCR.2. Materials and methods
2.1. Animals
Male C57BL/6 mice carrying Wnt1-Creþ / were mated with
C57BL/6 females that were homozygous for the Rosa26-LoxP-Stop-
LoxP-YFP reporter locus. The stage of embryonic development was
set to E0.5 on the day the vaginal plug was seen. Embryos carrying
both Wnt1-Cre and Rosa26-LoxP-Stop-LoxP-YFP were identified
based on YFP expression in the gastrointestinal tract and cranio-
facial tissues.
2.2. ENCC isolation, culture conditions and RET activation
Full-length guts (foregut to hindgut) were dissected from E14.5
embryos. Single cell suspensions were made using 0.05 mg/ml
Collagenase XI/Dispase II (Sigma Aldrich, St. Louis, MO, USA), fol-
lowed by incubation for 3–5 min at 37 °C and trituration. YFP-
positive ENCCs were FACS sorted and directly seeded in Fi-
bronectin-coated plates containing DMEM/F-12 medium (Invitro-
gen, Carlsbad, CA, USA) supplemented with 1% N2 supplement
(Invitrogen), 2% B27 supplement (Invitrogen), 20 ng/ml FGF (Pe-
protech EC, London, UK), 20 ng/ml EGF (Peprotech EC) and 1%
Penicillin-Streptomycin (Invitrogen). YFP-positive ENCCs from one
gut were equally divided over two wells; one of which was sup-
plemented with 50 ng/ml GDNF (Peprotech EC). ENCCs were in-
cubated at 37 °C for 14 days in a humidified atmosphere with 5%
CO2. Neurosphere-like bodies appeared after 3–5 days and were
kept in culture for 14 days without passaging.
2.3. Immunostaining
Wells with neurosphere-like bodies were fixed with 4% PFA for
15 min at room temperature (RT) and washed with PBSþ1%Triton
X 100 (PBT) for 25 min. They were incubated in blocking solu-
tion (PBTþ1%BSAþ0.15% glycine) for 1 h at RT followed by pri-
mary antibodies diluted in blocking solution overnight (O/N) at
4 °C: rabbit anti-human p75 (1:500, Promega, UK), mouse-anti
βIII-Tubulin (1:500, Covance UK). After several washes in PBT,
secondary antibodies were applied: goat anti-rabbit Alexa Fluor
568 and goat anti-mouse Alexa Fluor 568 (1:500, Invitrogen) O/N.
DAPI was added to secondary antibodies (1:1000). Antibody was
washed off (315 min with PBT). Slides were mounted using
Vectashield (Vector labs, UK) and visualized using confocal mi-
croscopy imaging on Zeiss LSM 710 (Zeiss, Cambridge, UK).
2.4. RNA isolation and gene expression quantification
RNA was isolated from untreated and GDNF-treated ENCC
cultures, as well as from uncultured E14.5 embryonic guts using
the RNeasy Mini Kit (Qiagen, Crawel, UK). RNA yield, purity and
integrity were determined using the Agilent 2100 BioAnalyzer
with 6000 Nano Chips (Agilent Technologies, Amsterdam, The
Netherlands). DNA microarray analyses and RNA quality controls
were performed by ServiceXS (Leiden, The Netherlands) using
GeneChip Mouse Genome 430 2.0 arrays (Affymetrix, Santa Clara,
CA, USA). For the ENCC vs gut experiment, 3 ENCC samples and
8 mouse gut samples entered the analysis. For the ENCCþGDNF vs
ENCC experiment, 7 pairs of untreated and GNDF-treated ENCC
cultures were analyzed.
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Quantile normalization and background correction were ap-
plied to the raw intensity values of all samples using Partek ver-
sion 6.4 (Partek Incorporated, St. Louis, MO, USA) via GC Robust
Multichip Analysis. For the ENCC vs gut analysis, 2 sample T testFig. 1. Isolation and characterization of ENCCs. A) Schematic overview of the Wnt1-C
expressed YFP in neural crest-derived cells, including craniofacial tissue and ENCCs. B) YF
presence or absence of GDNF for 14 days. RNAwas isolated from ENCCs as well as whole g
C) ENCCs expressed the neural crest marker p75/NGFR at both 24 h and 14 days after isola
ENCC cultures treated with GNDF.statistics were applied in Partek to calculate the fold changes with
associated p-values. Paired T test statistics were applied to calcu-
late the fold changes with associated p-values for the
ENCCþGDNF vs ENCC analysis. The fold change and p-value data
were uploaded into Ingenuity Pathway Analysis (IPA) (Ingenuity/
Qiagen, Redwood City, CA, USA). The probe level data was mappedre:Rosa26-YFP mouse model. At embryonic day 14.5, transgenic mouse embryos
P-expressing ENCCs were FACS-sorted from dissected guts and were cultured in the
ut tissue and relative RNA expression levels were quantified by microarray analysis.
tion. Pronounced βIII-Tubulin-positive connections between NLBs were observed in
D. Schriemer et al. / Developmental Biology 416 (2016) 255–265258to the gene level and averaged based on the median fold change
values. For the differential gene expression analysis, significance
thresholds of fold change 45 and p-valueo1E-5 were applied for
the ENCC vs gut comparison. For the ENCCþGDNF vs ENCC ana-
lysis, significance thresholds were set at fold change 41.8 and
p-valueo0.05. Gene Ontology enrichment was performed using
DAVID Bioinformatics Resources 6.7 and Upstream Regulator
Analysis was performed in IPA. For the Upstream Regulator Ana-
lysis the significance thresholds were set to z-score41.8 and
p-valueo0.05. Hierarchical clustering of Upstream Regulators and
their downstream target genes was performed using the heatmap
functionality in the HIV sequence database (http://www.hiv.lanl.
gov).
2.6. Quantitative real-time PCR
Gastrointestinal tracts from E14.5 Wnt1-Cre:Rosa26-YFP mice
were dissociated and FACS-sorted as describe above. YFP-positive
cells were collected in 100 ml TRIzol reagent (Life Technologies,
UK) and stored at 80 °C until RNA extraction. Guts from non-YFP
embryos from the litter were also dissected out and frozen in
TRIzol Reagent. Once thawed, samples were homogenized and
RNA was extracted according to manufacturer's instructions. cDNA
was synthesized using the iScript cDNA Synthesis kit (Bio-Rad).
Quantitative real-time (qRT)-PCR primers were designed in Pri-
mer-BLAST software. KAPA SYBR FAST qPCR Kit (Kapa Biosystems)
was loaded with primers and cDNA samples to a 96-well Hard-
Shell PCR plate (Bio-Rad). qRT-PCR was carried out on a CFX96
Touch Real-Time PCR Detection System (Bio-Rad).3. Results
3.1. Isolation of Enteric Neural Crest Cells
To identify genes that are involved in ENS development, gene
expression profiles of pure populations of ENCCs were generated.
Mice expressing Cre recombinase under the neural crest-specific
Wnt1 promoter were crossed with mice carrying the Rosa26-LoxP-
Stop-LoxP-YFP locus. ENCCs were isolated at embryonic day E14.5,
since at this stage ENCCs express markers of both early and late
ENS development (Heanue and Pachnis, 2006). Double transgenic
mouse embryos expressed YFP in neural crest cells in craniofacial
and gastrointestinal tissues as expected (Fig. 1a). YFP-expressing
cells were isolated from E14.5 gut using Fluorescence activated cell
sorting (FACS) (Fig. 1b). In culture, these cells formed neurosphere-
like bodies (NLBs) within 3–5 days (Fig. 1c). Notably, NLBs from
GDNF-treated ENCCs were larger than NLBs from untreated ENCCs.
Compared to untreated cultures, GDNF-treated ENCC cultures
showed marked βIII-Tubulin-positive connections between NLBs,
indicating that GDNF treatment induced neuronal differentiation
of ENCCs (Fig. 1c). Both untreated and GDNF-treated ENCC cultures
expressed the neural crest marker p75/NGFR at both 24 h and 14
days in vitro.
3.2. E14.5 ENCCs are enriched for markers of neuronal development
and neuronal signaling
The gene expression profile of cultured ENCCs (harvested from
E14.5 embryos) was compared to E14.5 embryonic gut to identify
genes that are highly expressed by ENCCs. Since whole gut sam-
ples contain a variety of cell types, such as endothelial cells,
smooth muscle, connective tissue, serosa, enterochromaffin cells
and approximately 5% ENCCs, the expression profiles of ENCCs and
whole gut tissue are expected to be very different. Therefore, only
genes with an 45-fold change in gene expression (975 genes)were included in downstream analyses. Gene Ontology analysis
was performed to identify the biological pathways these genes are
involved in. ENCC-expressed genes were highly enriched for the
Gene Ontology terms transmission of nerve impulse, synaptic sig-
naling and cell-cell signaling, that are associated with neuronal
signaling (Fig. 2). In addition, genes that are highly expressed in
ENCCs play a role in biological-/cell adhesion and neuron differ-
entiation. 1187 genes were 45 times less abundantly expressed in
ENCCs than in the gut and these genes are involved in cell cycle
control, in particular during active cell division (M-phase). Al-
though the culturing period may have affected the expression of
cell cycle genes in the ENCCs, this finding is consistent with the
high proliferation rate of cells in the developing E14.5 mouse gut.
Interestingly, genes highly expressed by ENCCs (and low in gut
tissue) and genes highly expressed in total gut tissue (and low in
ENCCs), are both significantly enriched for Gene Ontology terms
biological- and cell adhesion and regulation of cell proliferation
(Fig. 2). However, these represent sets of genes with different
properties and localizations. Adhesion molecules in ENCCs in-
cluded genes expressed in the ENS, such as Immunoglobulin su-
perfamily cell adhesion molecules (Ncam1, Ncam2, L1cam, Nrcam),
(proto-)cadherins (Cdh2, Cdh6, Pcdh15, Pcdha4) and integrins
(Itga4) (McKeown et al., 2013). Of note, Cdh13 was highly ex-
pressed by ENCCs and its human orthologue CDH13 maps to the
HSCR susceptibility locus 16q23.3 (Carrasquillo et al., 2002). Ad-
hesion molecules that were highly expressed in total gut tissue
included Cdh1, which is expressed by Paneth cells and goblet cells
in the intestinal epithelium (Schneider et al., 2010), the Claudin
family of tight junction molecules (CLDN 2, 3, 4, 5, 6, 7, 8, 15 and
23), as well as genes involved in the apical junction complex
(Desmocollin 2, Desmoglein 2, Plakophilin 2 and 3). These gut-ex-
pressed junction molecules are most likely expressed by the en-
terocytes of the intestinal epithelium.
3.3. GDNF treatment of ENCCs induces terminal neuronal
differentiation
RET signaling is critical during all stages of ENS development
and is important for survival, neuronal differentiation and neurite
outgrowth at E14-E16 (Chalazonitis et al., 1998; Hearn et al., 1998;
Natarajan et al., 2002; Taraviras et al., 1999; Young et al., 2001). To
identify the molecular pathways underlying these processes, the
changes in gene expression in ENCCs after 14 days of GDNF
treatment were analyzed. Compared to untreated ENCCs, the ex-
pression of 445 genes was at least 1.8 times higher in GDNF-
treated ENCCs. The neuronal signaling genes that were highly
expressed by ENCCs compared to the gut were even further up-
regulated upon GDNF treatment (Fig. 2). This finding suggests that
GDNF treatment induced terminal neuronal differentiation in
E14.5 ENCCs and is consistent with the pronounced βIII-Tubulin-
positive connections that were observed between NLBs grown
from GDNF-treated ENCCs (Fig. 1c). Additionally, the expression
levels of 352 genes was at least 1.8 times reduced by treatment
with GDNF, including genes involved in biological- and cell adhe-
sion and neuron differentiation. The adhesion molecules that are
down-regulated by GDNF include Cdh13, Col5a1, Fibronectin-1,
Reelin, Thrombospondin 1 and 4, and Vcam1. These adhesion mo-
lecules are involved in cell migration and cell motility, and thus
corroborate the observation that ENCCs stop migrating when they
undergo terminal neuronal differentiation (Young et al., 2004,
2005). Consistent with its proliferative role in ENCCs and its in-
hibitory effect on neuronal differentiation, endothelin receptor
type B (Ednrb) expression was down-regulated by GDNF. The
down-regulation of genes involved in neuron differentiation and
up-regulation of neuronal signaling genes, shows that different
genes are involved in early and late neuronal development.
Fig. 2. Gene Ontology analysis of differentially expressed genes. Differentially expressed genes between ENCCs and the gut, and between untreated and GDNF-treated ENCCs
were annotated by Gene Ontology enrichment analysis. Values represent multiple testing corrected (Benjamini) p-values. The six most significant Gene Ontology terms per
gene set are given and these are partially overlapping between the different sets of genes.
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but the molecular mechanisms controlling neuronal subtype
specification in the ENS are poorly understood. To test whether
RET signaling in ENCCs contributes to the specification of neuronal
subtypes, the expression of neuronal subtypes markers was de-
termined in untreated and GDNF-treated ENCCs. The expression
levels of cholinergic (Acat2, Ache, Chrna5), glutamatergic (Grik2,
Gria1, Grid2) and GABAergic (Gabra1, Gabrg2, Gabrg3) markers
were increased by GDNF, as well as the expression of CART pre-
propeptide (Cartpt), NPY receptor Y2 (Npy2r), Substance P pre-
cursor Tac1, Dopamine beta-hydroxylase (Dbh) and Vasoactive
intestinal peptide (Vip). The elevated expression of these subtype
markers supports our observation that RET signaling is involved in
terminal neuronal differentiation of ENCCs. Several other neuronalsubtype markers, such as 5-HT, Calbindin, Calretinin, CGRP, En-
kephalin and NOS were not differentially expressed. The wide
range of neuronal subtypes markers that are up-regulated by
GDNF suggests that RET signaling might be involved in the spe-
cification of different, but not all, neuronal subtypes.
3.4. Upstream Regulator Analysis identifies known and new genes
important for ENS development
Having identified gene expression patterns in untreated and
GDNF-treated ENCCs, we next aimed to identify regulatory genes
in ENCCs and in GDNF-induced neuronal maturation. To address
this, we used the Upstream Regulator Analysis tool in Ingenuity
Pathway Analysis (IPA). Upstream Regulators are predicted to
Table 1
Upstream Regulators of gene expression in naïve and GDNF-treated ENCCs. Regulatory genes in ENCCs were predicted by IPA Upstream Regulator Analysis. Significant
Upstream Regulators were defined as having an activation z-score41.8 and p-value of overlap o0.05. From the Upstream Regulator Analysis, genes were selected that were
expressed 45 times higher in ENCCs than in the gut, or that were 41.8 times up-regulated by GDNF. The Upstream Regulators can be linked to ENS development and HSCR
(also see Fig. 5).
Dataset Upstream Regulator Activation z-score p-Value of overlap Target genes Fold change Link to HSCR
High in ENCCs Cdkn2a 5.196 1.65E07 55 467.6
Nupr1 4.740 2.51E16 127 6.2
Bdnf 3.286 1.37E05 46 9.2 Regulator of SNAP25 and VAMP2; migration of ENCCsa
App 2.931 1.47E12 157 7.1 Overexpression (Down syndrome) causes neuronal lossb
Regulator of SNAP25 and VAMP2; migration of ENCCsa
Inhibitor of MMP2 that is important for migration of
ENCCsc
Sox10 2.596 1.56E03 9 19.8 Known HCSR gened
Ret 2.359 9.10E05 29 16.5 Known HSCR genee
Mapk10 2.195 6.71E03 5 22.7 Deletion in HSCR patientf
Phosphorylates APP and STMN2g
Elavl1 2.183 1.98E02 16 5.4
Timp1 1.890 1.38E02 7 7.9
Up by GDNF Adora2a 1.941 8.39E02 10 1.9
Npy2r 1.727 2.58E03 4 1.9 Maps to HSCR susceptibility locus 4q31.3-q32.3h
a Vohra et al. (2006).
b Salehi et al. (2006), Trazzi et al. (2013) and Semar et al. (2013).
c Anderson (2010).
d Pingault et al. (1998).
e Edery et al. (1994) and Romeo et al. (1994).
f Jiang et al. (2011).
g Kimberly et al. (2005) and Neidhart et al. (2001).
h Brooks et al. (2006).
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into account the enrichment for genes that are known to be
regulated by a particular Upstream Regulator (p-value of overlap)
and the direction of differential gene expression (activation
z-score) (Krämer et al., 2014). Many genes that are known to have
important regulatory functions in ENS development are highly
expressed by ENCCs. Therefore, genes were selected from the
Upstream Regulator Analysis that were either highly expressed by
ENCCs or up-regulated by GDNF. The Upstream Regulator AnalysisFig. 3. Expression of the Upstream Regulators in acutely isolated ENCCs. Except for Cdkn
isolated, uncultured ENCCs from E14.5 embryonic gut. The expression levels of Elavl1, Nu
that the high expression of these genes in the microarray data was induced by culturing
isolated, uncultured cells. Adora2a and Npy2r were near-significant regulators of gene ex
ENCCs. *Benjamini-Hochberg adjusted p-valueo0.05.of differentially gene expression between ENCCs and the gut
yielded nine regulatory genes that are highly expressed by ENCCs
themselves (Table 1).
These Upstream Regulators were expressed in ENCCs that were
cultured in vitro for 14 days. To confirm that these genes are en-
dogenously expressed in ENCCs, qRT-PCR analysis was performed
on RNA from acutely isolated, uncultured ENCCs from E14.5 em-
bryonic gut. The cell cycle-associated genes Elavl1 and Nupr1 were
not differentially expressed between uncultured ENCCs and whole2a, all predicted Upstream Regulators were detected by qRT-PCR analysis on acutely
pr1 and Timp1 were not higher in uncultured ENCCs than in whole gut, suggesting
. The high expression of Sox10, Ret, Bdnf, App and Mapk10 was confirmed in acutely
pression in GDNF-treated ENCCs and both genes were expressed in acutely isolated
D. Schriemer et al. / Developmental Biology 416 (2016) 255–265 261gut samples (Fig. 3). Timp1, although expressed in acutely isolated
ENCCs, was expressed in ENCCs at lower levels than in whole gut.
Cdkn2a expression levels were below the detection limit, sug-
gesting that the gene was very lowly or not expressed in un-
cultured ENCCs. These data suggest that the high gene expression
levels of Elavl1, Nupr1, Timp1 and Cdkn2a in cultured ENCCs was
due to the culture conditions.
The Upstream Regulators with a high expression in acutely
isolated ENCCs compared to whole gut were Sox10, Ret, Bdnf, App
and Mapk10. Of these genes, Sox10 and Ret are well-established
ENS development genes. SOX10 is a transcription factor that is
required for survival of ENCCs and maintenance of their progenitor
state (Bondurand et al., 2006; Kapur, 1999). The identification of
Ret and Sox10 as regulatory genes in ENCCs demonstrates the va-
lidity of the Upstream Regulator Analysis and suggests that the
remaining Upstream Regulators and their respective pathways are
key regulators of ENS development. These remaining Upstream
Regulators are Bdnf, App and Mapk10.
Brain Derived Neurotrophic Factor (Bdnf) is expressed by ENCCs
and the mucosa and its receptors TRKB and p75/NGFR are abun-
dantly expressed in the human and mouse ENS (Hoehner et al.,
1996; Lommatzsch et al., 1999). BDNF signaling promotes neuronal
survival, growth and differentiation and functions in the mature
ENS by controlling peristalsis and colonic emptying (Coulie et al.,
2000; Grider et al., 2006).
Amyloid Precursor Protein (App) is the precursor of Amyloid-β
plaques in Alzheimer disease. The endogenous function of APP is
not completely understood, but APP has been shown to be in-
volved in synapse formation and plasticity and is expressed in the
human ENS (Arai et al., 1991; Cabal et al., 1995; Turner et al., 2003;
Tyan et al., 2012).
Mitogen-Activated Protein Kinase 10 (Mapk10/Jnk3) is highly
expressed by ENCCs (Heanue and Pachnis, 2006). MAPK10 is in-
volved in a broad range of processes, including proliferation, dif-
ferentiation, inflammation, cellular stress and neuronal apoptosis
and is regulated by RET signaling in ENCCs (Ngan et al., 2008).
3.5. Adenosine and neuropeptide Y signaling modulate GDNF-in-
duced changes in gene expression
Upstream Regulator Analysis of GDNF-induced changes in gene
expression did not result in any genes that have both a significant
activation z-score and p-value. There are, however, two Upstream
Regulators with near-significant z-scores and p-values; the ade-
nosine receptor A2a (Adora2a) and the neuropeptide Y receptor Y2
(Npy2r). Adora2a and Npy2r were both expressed in acutely iso-
lated ENCCs from E14.5 embryos and Npy2r was more abundantly
expressed in ENCCs than in whole gut (Fig. 3). Adenosine regulates
intestinal secretion, motility and immune responses and acts
through adenosine receptors A1, A2a, A2b and A3. The adenosine
A2a receptor is expressed by the myenteric- and submucosal
plexuses in both the small and large intestine (Antonioli et al.,
2008). ADORA2A modulates intestinal motility by inhibiting motor
activity in the duodenum and colon of mice and humans, re-
spectively (Fornai et al., 2009; Zizzo et al., 2011), thereby allowing
relaxation of the bowel.
Npy2r encodes the neuropeptide Y receptor Y2, a receptor for
neuropeptide Y (NPY) and peptide YY (PYY) (Chen et al., 1997).
NPY and PYY induce colonic smooth muscle relaxation and inhibit
intestinal contractility and motility in response to feeding, which
is exerted through the neuropeptide Y1 and Y2 receptors (Hell-
ström, 1987; Tough et al., 2011).
3.6. Synergistic regulation of gene expression
The predicted Upstream Regulators each have between 4 and157 downstream targets, combining up to 213 unique genes. Al-
though a single Upstream Regulator regulates the expression of
most of these genes, there are also 38 genes that are regulated by
multiple regulatory genes (Fig. 4). Many of the genes that are
regulated by three or more Upstream Regulators are known to play
a role in the ENS, such as App, c-Jun, Nos1, IL-6, Napb, (p75/)Ngfr
and Npy. Hierarchical clustering of downstream target genes
showed that there are clusters of co-regulated genes with similar
functions. For example, Bdnf, Gap43, Mapt, Mbp, Penk, Snap25,
Syn1, Syn2, Syp, Tubb3 and Vamp2 all are involved in synaptic
signaling and are synergistically regulated by Bdnf and App. Like-
wise, Prnp, Klk3, D cn , Calb1, Ccl2, Cd151, Csf1, Ctsb, Cxcl12, Dpysl2
and Stmn2 are regulated by both Ret and App. The synergistic
regulation of downstream target genes by multiple Upstream
Regulators provides insight into the molecular networks under-
lying ENS development.4. Discussion
In this study we have analyzed gene expression profiles of
GDNF-treated and untreated mouse ENCCs (isolation time E14.5)
and E14.5 mouse embryonic gut. Unbiased, systematic Gene On-
tology analysis showed that, compared to the whole gut, ENCCs
highly express genes involved in cell adhesion, neuronal differ-
entiation and synaptic signaling, representing various aspects of
ENS development. These data corroborate findings by Heanue and
Pachnis (Heanue and Pachnis, 2006). These authors compared
gene expression profiles of E15.5 ganglionic (Retþ /þ) and agan-
glionic (Retk /k) gut and found that ENCCs express markers of
early differentiating glia and neurons, terminally differentiated
neurons, axonal outgrowth and synaptogenesis. In fact, of the 47
genes that were confirmed to be expressed in the ENS by in situ
hybridization in that study, 35 genes (74%) were highly expressed
by ENCCs in our study. Likewise, the gene expression study by
Vohra et al. confirmed expression in the ENS for 38 genes by
in situ hybridization, of which 23 genes (61%) were differently
expressed between ENCCs and the gut in the present study (Vohra
et al., 2006). Of the 105 ENCC-expressed genes found by Iwashita
et al., 19 genes (18%) overlap with our data (Iwashita et al., 2003).
Importantly, this shows that the 14 days in vitro culturing of
ENCCs in our study did not lead to major changes in gene ex-
pression. Of the 975 genes that were expressed higher in ENCCs
than in total gut tissue, 848 genes (87%) were not reported in any
of the three expression studies mentioned above. However, part of
these 848 genes are already reported to be involved in ENS de-
velopment (Kuo et al., 2010; Teng et al., 2008). This study therefore
represents a more complete catalog of known and newly identified
genes that are expressed in the developing ENS.
4.1. Regulators of gene expression in ENCCs are putative HSCR genes
Sox10, Ret, Bdnf, App and Mapk10 were identified as genes that
are highly expressed in ENCCs and that regulate the expression of
other ENCC-expressed genes. Of these regulators, RET and SOX10
are known HSCR genes. Mutations in RET and SOX10 contribute to
HSCR in humans and mice with null mutations for Ret and Sox10
display total intestinal aganglionosis (Edery et al., 1994; Herbarth
et al., 1998; Pingault et al., 1998; Romeo et al., 1994; Schuchardt
et al., 1994; Southard-Smith et al., 1998). Given the known neu-
ronal functions of Bdnf, App, andMapk10, this raises the hypothesis
that these regulatory genes might also be implicated in HSCR and
other neuropathies, such as intestinal pseudo-obstruction, incon-
tinence or constipation.
Mapk10 is a highly interesting regulator of gene expression in
ENCCs with regard to HSCR. MAPK10 modulates neuronal
Fig. 4. Upstream Regulators regulate gene expression synergistically. The regulation of downstream target genes (right-hand side) by Upstream Regulators (bottom) is
shown for all genes that are regulated by two or more Upstream Regulators. Red and blue boxes indicate regulation by an Upstream Regulator in naïve and GDNF-treated
ENCCs, respectively. Yellow indicates that the gene is not regulated by the specific Upstream Regulator.
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(Kimberly et al., 2005; Neidhart et al., 2001). STMN2 (SCG10) in-
teracts with Kinesin Binding Protein (KBP, KIAA1279) and muta-
tions in KBP have been linked to the HSCR-associated Goldberg-
Shprintzen Syndrome (Alves et al., 2010; Brooks et al., 2005b). Loss
of MAPK10 could therefore contribute to HSCR through impaired
APP and/or STMN2 signaling in enteric neuron differentiation.
Since Mapk10was reported to be highly expressed in ENCCs, it was
included in a copy number variant screen for candidate genes in
HSCR (Jiang et al., 2011). The authors reported one deletion in
MAPK10 among 18 HSCR patients. Segregation analysis showed
that the MAPK10 deletion was neither necessary nor sufficient to
cause HSCR in this family and the authors therefore hypothesized
that the deletion inMAPK10 acts as a modifier for developing HSCR
(Jiang et al., 2011).
ENS development is of interest in relation to Down syndrome
(Trisomy 21). The incidence of HSCR in Down syndrome is 2.6%,
which is over a hundred times higher than in the general popu-
lation (Friedmacher and Puri, 2013). This suggests that the dupli-
cation of one or more genes on chromosome 21 contributes to the
onset of HSCR. APP is located on chromosome 21 in humans andApp is an Upstream Regulator of gene expression in the developing
murine ENS. It has been shown that overexpression of wild type
human APP in mice causes loss of cholinergic neurons through
disruption of Nerve Growth Factor transport and impairs neuro-
genesis in the CNS (Salehi et al., 2006; Trazzi et al., 2013). More-
over, mice overexpressing an Alzheimer's disease mutant form of
APP show reduced neuronal density in the myenteric plexus and
altered intestinal motility (Semar et al., 2013). In the latter study it
is not clear, however, whether the phenotype was caused by the
increased expression level of APP or by the presence of the Alz-
heimer mutation in the overexpressed gene. APP contains an in-
hibitor domain that inhibits matrix metalloproteinase 2 (MMP2)
(Miyazaki et al., 1993) and pharmacological inhibition of MMP2
impairs the migration of ENCCs along the mouse gut (Anderson,
2010). Inhibition of MMP2 is another mechanism by which over-
expression of APP might contribute to the development of HSCR in
Down syndrome. These reports, combined with the regulatory
function of App in ENCCs, raise the intriguing hypothesis that
overexpression of APP might contribute to the high incidence of
HSCR and other gastrointestinal abnormalities in Down syndrome
patients.
Fig. 5. Hypothetical molecular network implicating Upstream Regulators in HSCR.
The Upstream Regulators in ENCCs are either known HSCR genes (RET and SOX10),
can be linked to a known HSCR gene (KBP), or can be linked to genes that are
critical for colonization of the gut by ENCCs (SNAP25, VAMP2 andMMP2). The link of
each Upstream Regulator to HSCR and the respective references are summarized in
Table 1. Arrows indicate activation and blunted lines indicate inhibition. Solid lines
represent direct interactions in ENCCs. Dotted lines represent indirect interactions
and evidence from other cell types.
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eral downstream target molecules that are involved in synaptic
signaling, including Snap25 and Vamp2. Snap25 and Vamp2 med-
iate the fusion of synaptic vesicles and the high expression of
these genes in ENCCs was reported by Vohra et al., who subse-
quently showed that Snap25 and Vamp2 are important for ENCC
migration and neurite outgrowth (Vohra et al., 2006). Since both
genes are regulated by APP and BDNF, aberrant APP and BDNF
signaling might result in similar defects in ENS development.
As discussed here, the Upstream Regulators with neuronal
functions are either known HSCR genes, or are linked to the mo-
lecular pathways underlying HSCR or animal models of aganglio-
nosis. There is a large body of literature suggesting interactions
between these genes, allowing us to construct a hypothetical
network of regulatory genes in ENCCs (Fig. 5). The transcription
factor SOX10 binds to an enhancer of Ret, thereby regulating Ret
expression (Lang and Epstein, 2003). In turn, RET activates the
MAPK pathway, including MAPK10 (Ngan et al., 2008; Plaza-Me-
nacho et al., 2006). MAPK10 phosphorylates APP, which regulates
the expression of synaptic genes Snap25 and Vamp2 together with
BDNF, and inhibits MMP2 activity (Kimberly et al., 2005; Miyazaki
et al., 1993). MAPK10 also phosphorylates STMN2, leading to cy-
toskeletal remodeling in conjunction with KBP (Alves et al., 2010;
Neidhart et al., 2001).
4.2. Modulators of RET-signaling in ENCCs
Several signaling cascades are activated by RET, including Pi3K/
AKT, ERK, p38-MAPK and JNK pathways (Plaza-Menacho et al.,
2006). Little is known, however, how these pathways contribute to
RET-induced proliferation, migration, differentiation and survival
of ENCCs. Similar to our study, Ngan et al. analyzed the changes in
gene expression induced by GDNF treatment of ENCCs and found
that the expression levels of 29 genes were increased by GDNF
treatment. Only 4 of these 29 genes were up-regulated by GDNF in
our data. These different findings can be explained by two fun-
damental differences in study design, duration of GDNF stimula-
tion and developmental stage of ENCCs. Ngan et al. investigatedthe short-term changes (8 and 16 h GDNF treatment) in E11.5
ENCCs, when RET is required for migration and proliferation. In the
present study, on the other hand, we have analyzed the long-term
changes (14 days GDNF treatment) in ENCCs at E14.5, a stage in
which RET is involved in survival and differentiation. The four
genes that are up-regulated by GDNF treatment in both studies
(Kcnd2, Vip, Olfm1 and Tagln3), are therefore likely to be critical
modulators of RET signaling and are possibly involved in different
aspects of ENS development.
Long-term GDNF treatment of ENCCs resulted in reduced ex-
pression levels of genes involved in neuronal migration and early
neuronal differentiation. Conversely, GDNF increased the expres-
sion of genes that are associated with terminal neuronal differ-
entiation and synaptic signaling. Upstream Regulator Analysis
showed that the adenosine receptor A2a and the neuropeptide Y
receptor Y2 are near-significant modifiers of these cellular pro-
cesses in GDNF-treated ENCCs. Signaling via NPY2R modulates the
neurotrophic effect of GDNF on ENCCs, as a study by Anitha et al.
(2006) has shown that GDNF treatment of ENCCs results in in-
creased proliferation and reduced apoptosis of ENCCs in a NPY-
dependent manner. This report is in line with our observation that
NLBs from GDNF-treated ENCCs are larger than NLBs from un-
treated ENCCs. Of interest, the human orthologue of Npy2rmaps to
the HSCR susceptibility locus 4q31.3-q32.3 and increased NPY le-
vels have been reported in aganglionic bowel segments from HSCR
patients (Brooks et al., 2006; Hamada et al., 1987).5. Concluding remarks
In conclusion, systematic analysis of E14.5 ENCCs gene ex-
pression profiles showed that they express markers of neural mi-
gration, axonal outgrowth and neuronal signaling. Upstream
Regulator Analysis predicted genes that serve critical regulatory
functions during ENS development and we propose a mechanistic
network of action for these regulatory genes. Additionally, we
found that GDNF treatment of ENCCs caused terminal neuronal
differentiation into a variety of neuronal subtypes. These reg-
ulatory genes in ENS development give insight into the molecular
pathways regulating ENS development and provide novel candi-
date genes for HSCR.Acknowledgement
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